Surface Oncology, Inc. Common Stock
SURF
SURF was delisted on the 7th of September, 2023.
35 hedge funds and large institutions have $20.9M invested in Surface Oncology, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 15 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
26% less funds holding
Funds holding: 47 → 35 (-12)
53% less capital invested
Capital invested by funds: $44.4M → $20.9M (-$23.5M)
53% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 17
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
RBF Capital
San Francisco,
California
|
+$221K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$192K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$188K |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$142K |
| 5 |
Renaissance Technologies
New York
|
+$56.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.67M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$250K |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$221K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$209K |
| 5 |
Millennium Management
New York
|
-$125K |
SURF Hedge Fund Activity: Q3 2019 in Review
35 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q3 2019, worth a combined $20.9M — down 53% from $44.4M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of SURF and 3 opened new positions — a net loss of 12 holders — while 17 trimmed existing stakes and 8 added.
The largest buyer was RBF Capital, opening a new position worth an estimated $221K. The largest seller was EcoR1 Capital, cutting an estimated $1.67M.
- 35 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q3 2019, down from 47 in Q2 2019.
- Funds reported $20.9M of Surface Oncology, Inc. Common Stock stock for Q3 2019, down 53% quarter-over-quarter.
- 3 funds opened new Surface Oncology, Inc. Common Stock positions in Q3 2019 and 15 closed out, a net change of -12 holders.
- The largest Surface Oncology, Inc. Common Stock buyer in Q3 2019 was RBF Capital, an estimated $221K added.
- The largest Surface Oncology, Inc. Common Stock seller in Q3 2019 was EcoR1 Capital, an estimated $1.67M sold.
Based on aggregated 13F filings for Q3 2019.